Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice

Journal of Clinical Investigation

Volumn 99, Issue 5, 1997, Pages 1064-1071

  Mould, Arne W ^a   Matthaei, Klaus I ^a   Young, Ian G ^a   Foster, Paul S ^a  

^a Biology and Environment   (Australia)

Author keywords

chemotaxis; eosinophils; eotaxin; homing; interleukin 5

Indexed keywords

CHEMOATTRACTANT; CHEMOKINE; INTERLEUKIN 5;

ADOPTIVE TRANSFER; ALLERGY; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOASSAY; BONE MARROW; CHEMOTAXIS; CONTROLLED STUDY; EOSINOPHIL; EOSINOPHILIA; INFLAMMATION; LEUKOCYTE MIGRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030907876     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119234     Document Type: Article

References (37)

1. Rothenberg, M.E., W.F. Owen, Jr., D.S. Silberstein, J. Woods, R.J. Soberman, K.F. Austen, and R.L. Stevens. 1988. Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3. J. Clin. Invest. 81:1986-1992.
2. Owen, W.F., Jr., M.E. Rothenberg, D.S. Silberstein, J.C. Gasson, R.I. Stevens, K.F. Austen, and R.J. Soberman. 1987. Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibro blasts. J. Exp. Med. 166:129-141.
3. Yamaguchi, Y., T. Suda, J. Suda, M. Eguchi, Y. Miura, N. Harada, A. Tominaga, and K. Takatsu. 1988. Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. J. Exp. Med. 167:43-56.
4. Clutterbuck, E.J., E.M. Hirst, and C.J. Sanderson. 1989. Human interleukin 5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparisons and interactions with IL-1, IL-3, IL-6 and GM-CSF. Blood. 73:1504-1512.
5. Fujisawa, T., R. Abu-Ghazaleh, H. Kita, C.J. Sanderson, and G.J. Gleich. 1990. Regulatory effects of cytokines on eosinophil degranulation. J. Immunol. 144:642-646.
6. Lopez, A.F., C.J. Sanderson, J.R. Gamble, H.D. Campbell, I.G. Young, and M.A. Vadas. 1988. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J. Exp. Med. 167:219-224.
7. Coffman, R.L., B.W.P. Seymour, S. Hudak, J. Jackson, and D. Rennick. 1989. Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science (Wash. DC). 245:308-310.
8. Pober, J.S., M.A. Gimbrone, L.A. Lapierre, Jr., D.L. Mendrick, W. Fiers. R. Rothlein, and T.A. Springer. 1986. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J. Immunol. 137:1893-1896.
9. Walsh, G.M., A. Hartnell, A.J. Wardlaw, K. Kurihara, C.J. Sanderson, and A.B. Kay. 1990. IL-5 enhances the in vitro adhesion of human eosinophils, hut not neutrophils, in a leucocyte integrin (CD11/18)-dependent manner. Immunology. 71:258-265.
10. 1 (very late antigen-4) dependent. J. Immunol. 146:3419-3423.
11. Schleimer, R.P., S.A. Sterbinsky, J. Kaiser, C.A. Bickel, D.A. Klunk, K. Tomioka, W. Newman, F.W. Luscinskas, M.A. Gimbrone, Jr., B.W. McIntyre, and B.S. Bochner. 1992. IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Associations with expression of VCAM-1. J. Immunol. 148:1086-1092.
12. Ebisawa, M., B.S. Bochner, S.N. Georas, and R.P. Schleimer. 1992. Eosinophil trans endothelial migration induced by cytokines. I. Role of endothelial and eosinophil adhesion molecules in IL-1β-induced trans endothelial migration. J. Immunol. 149:4021-4028.
13. Ebisawa, M., M.C. Liu, T. Yamada, M. Kato, L.M. Lichtenstein, B.S. Bochner, and R.P. Schleimer. 1994. Eosinophil trans endothelial migration induced by cytokines. II. Potentiation of eosinophil trans endothelial migration by eosinophil-active cytokines. J. Immunol. 152:4590-4596.
14. Dahinden, C.A., T. Geiser, T. Brunner, V. von Tscharner, D. Caput, P. Ferrara, A. Minty, and M. Baggiolini. 1994. Monocyte chemotactic protein 3 is a most effective basophil and eosinophil-activating chemokine. J. Exp. Med. 179:751-756.
15. Rot, A., T. Krieger, T. Brunner, S.C. Bischoff, T.J. Schall, and C.A. Dahinden. 1992. RANTES and macrophage inflammatory protein 1α induce the migration and activation of normal human eosinophil granulocytes. J. Exp. Med. 176:1489-1495.
16. Jose, P.J., D.A. Griffiths-Johnson, P.D. Collins, D.T. Walsh, R. Moqbel, N.F. Totty, O. Truong, J.J. Hsuan, and T.J. Williams. 1994. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea-pig model of allergic airways inflammation. J. Exp. Med. 179:881-887.
17. Rothenberg, M.E., A.D. Luster, and P. Leder. 1995. Murine eotaxin: an eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression. Proc. Natl. Acad. Sci. USA. 92:8960-8964.
18. 2-type response. Immunity. 4:1-14.
19. 111In-eosinophils induced by inflammatory mediators, in vivo. Immunology. 73:222-227.
20. Warringa, R.A.J., H.J.J. Mengelers, P.H.M. Kuijper, J.A.M. Raaijmakers, P.L.B. Bruijnzeel, and L. Koenderman. 1992. In vivo priming of platelet-activating factor-induced eosinophil chemotaxis in allergic asthmatic individuals. Blood. 79:1836-1841.
21. Yamaguchi, Y., Y. Hayashi, Y. Sugama, Y. Miura, T. Kasahara, S. Kitamura, M. Torisu, S. Mita, A. Tominaga, K. Takatsu, and T. Suda. 1988. Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor. J. Exp. Med. 167:1737-1742.
22. Wang, J.M., A. Rambaldi, A. Biondi, Z.G. Chen, C.J. Sanderson, and A. Mantovani. 1989. Recombinant human interleukin 5 is a selective eosinophil chemoattractant. Eur. J. Immunol. 19:701-705.
23. Sehmi, R., A.J. Wardlaw, O. Cromwell, K. Kurihara, P. Wallmann, and A.B. Kay. 1992. Interleukin 5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects. Blood. 79: 2952-2959.
24. Iwama, T., H. Nagai, H. Suda, N. Tsuruoka, and A. Koda. 1992. Effects of murine recombinant interleukin-5 on the cell population in guinea-pig airways. Br. J. Clin. Pharmacol. 105:19-22.
25. Coeffier, E., D. Joseph, and B.B. Vargaftig. 1991. Activation of guinea pig eosinophils by human recombinant IL-5. Selective priming to platelet-activating factor-acether and interference of its antagonists. J. Immunol. 147:2595-2602.
26. Kopf, M., F. Brombacher, P.D. Hodgkin, A.J. Ramsay, E.A. Milbourne, W.J. Dai, K.S. Ovington, C.A. Behm, G. Kohler, I.G. Young, et al. 1996. IL-5 deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophils but have normal antibody and cytotoxic T cell responses. Immunity. 4:15-24.
27. Foster, P.S., S.P. Hogan, A.J. Ramsay, K.I. Matthaei, and I.G. Young. 1996. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity. and lung damage in a mouse asthma model. J. Exp. Med. 183:195-201.
28. Collins, P.D., S. Marleau, D.A. Griffiths-Johnson, P.J. Jose, and T.J. Williams. 1995. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J. Exp. Med. 182:1169-1174.
29. Kay, A.B., S. Ying, V. Varney, M. Gaga, S.R. Durham, R. Moqhel, A.J. Wardlaw, and Q. Hamid. 1991. Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colony stimulating factor, in allergen-induced late-phase cutaneous reaction in atopic subjects. J. Exp. Med. 173:775-778.
30. Hamid, Q., M. Azzawi, S. Ying, R. Moqbel, A.J. Wardlaw, C.J. Corrigan, B. Bradley, S.R. Durham, J.V. Collins, P.K. Jeffery, D.J. Quint, and A.B. Kay. 1991. Interleukin-5 in the pathogenesis of asthma. J. Clin. Invest. 87:1541-1546.
31. 2-like hronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326:298-304.
32. Kitaura, M., T. Nakajima, T. Imai, S. Harada, C. Combadiere, H.L. Tiffany, P.M. Murphy, and O. Yoshie. 1996. Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3. J. Biol. Chem. 271:7725-7730.
33. Rothenberg, M.E., R. Ownbey, P.D. Mehlhop, P.M. Loiselle, M. van de Rijn, J.V. Bonventre, H.C. Oettgen, P. Leder, and A.D. Luster. 1996. Eotaxin triggers eosinophil selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin-5 in mice. Mol. Med. 2:334-348.
34. Lawman, M.J.P., M.D.P. Boyle, A.P. Gee, and M. Young. 1984. A rapid technique for measuring leukocyte chemotaxis in vivo. J. Immunol. Methods. 69:197-206.
35. Discombe, G. 1946. Criteria of eosinophilia. Lancet. 1:195.
36. Ingley, E., R.L. Cutler, M.C. Fung, C.J. Sanderson, and I.G. Young. 1991. Production and purification of recombinant human interleukin-5 from yeast and baculovirus expression systems. Eur. J. Biochem. 196:623-629.
37. + T lymphocytes and interleukin-5 in antigen-induced eosinophil recruitment into the site of cutaneous late-phase reaction in mice. J. Leukocyte. Biol. 52:572-578.